Miami Cancer Institute | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
Miami Cancer Institute

Miami Cancer Institute

8900 North Kendall Drive
Miami, Florida, United States
Phone   Web  

Miami Cancer Institute forges new ground in cancer treatment, clinical expertise, research and discovery to pave the way for personalized care delivered with the heart of Baptist Health. Miami Cancer Institute at Baptist Health South Florida provides every diagnostic tool needed to accurately diagnose and stage myeloma. 

Myeloma is treated by a collaborative team of cancer physicians. This team includes hematology doctors who specialize in myeloma. These doctors are leaders in their field with years of clinical and research experience.

Diagnostic testing for myeloma at Miami Cancer Institute include:

• Blood tests – These tests look for excessive amounts of certain blood proteins and low blood counts, which are seen in people with myeloma. They are also used to stage the cancer.

• Urine tests – These tests can also reveal excessive amounts of blood proteins common in myeloma.

• Bone marrow aspiration or biopsy – These tests examine a sample of liquid bone marrow or solid bone marrow for the presence of excess plasma cells, which indicate myeloma.

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close